Form D · Biotechnology
ANALYTICAL BIO CHEMISTRY LABORATORIES INC
Columbia, MO · CIK 0000932570
Offering snapshot reported May 8, 2009 · SEC filing
- Reported sold
- $575K Offering amount: $575K
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 8, 2009 | Initial | $574,984 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-93257-0C
Source: Form D, filed May 8, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steve Adamson | Director |
| Nancy Adrian | Executive |
| Lester Bryant | Director |
| John Bucksath | Executive |
| Ron Carroll | Director |
| Dale Creach | Director |
| Marta Fahrenbrink | Executive |
| Byron Hill | Director, Executive |
| Susan Isaacson | Director |
| Kristein King | Executive |
| Ryan Mc Kenzie | Executive |
| Barry Orscheln | Director |
| Scott Ward | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7200 E. Abc Lane
Columbia, MO, 65202
Columbia, MO, 65202